289 related articles for article (PubMed ID: 28678827)
1. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.
Reyes-Gibby CC; Melkonian SC; Wang J; Yu RK; Shelburne SA; Lu C; Gunn GB; Chambers MS; Hanna EY; Yeung SJ; Shete S
PLoS One; 2017; 12(7):e0180396. PubMed ID: 28678827
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.
Murphy BA
J Support Oncol; 2007 Oct; 5(9 Suppl 4):13-21. PubMed ID: 18046994
[TBL] [Abstract][Full Text] [Related]
3. Natural Products for Management of Oral Mucositis Induced by Radiotherapy and Chemotherapy.
Aghamohamamdi A; Hosseinimehr SJ
Integr Cancer Ther; 2016 Mar; 15(1):60-8. PubMed ID: 26306626
[TBL] [Abstract][Full Text] [Related]
4. World Workshop on Oral Medicine VII: Non-opioid pain management of head and neck chemo/radiation-induced mucositis: A systematic review.
Christoforou J; Karasneh J; Manfredi M; Dave B; Walker JS; Dios PD; Epstein J; Kumar N; Glick M; Lockhart PB; Patton LL
Oral Dis; 2019 Jun; 25 Suppl 1():182-192. PubMed ID: 30811811
[TBL] [Abstract][Full Text] [Related]
5. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis.
Scully C; Epstein J; Sonis S
Head Neck; 2004 Jan; 26(1):77-84. PubMed ID: 14724910
[TBL] [Abstract][Full Text] [Related]
6. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.
Stokman MA; Spijkervet FK; Boezen HM; Schouten JP; Roodenburg JL; de Vries EG
J Dent Res; 2006 Aug; 85(8):690-700. PubMed ID: 16861284
[TBL] [Abstract][Full Text] [Related]
7. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
8. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
Trotti A; Bellm LA; Epstein JB; Frame D; Fuchs HJ; Gwede CK; Komaroff E; Nalysnyk L; Zilberberg MD
Radiother Oncol; 2003 Mar; 66(3):253-62. PubMed ID: 12742264
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
10. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies.
Li E; Trovato JA
Am J Health Syst Pharm; 2012 Jun; 69(12):1031-7. PubMed ID: 22644979
[TBL] [Abstract][Full Text] [Related]
11. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
[TBL] [Abstract][Full Text] [Related]
12. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
13. Regimen-related gastrointestinal toxicities in cancer patients.
Sonis ST
Curr Opin Support Palliat Care; 2010 Mar; 4(1):26-30. PubMed ID: 20040879
[TBL] [Abstract][Full Text] [Related]
14. Treatment of head and neck cancers: issues for clinical pharmacists.
Scarpace SL; Brodzik FA; Mehdi S; Belgam R
Pharmacotherapy; 2009 May; 29(5):578-92. PubMed ID: 19397465
[TBL] [Abstract][Full Text] [Related]
15. MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
Reyes-Gibby CC; Wang J; Silvas MR; Yu R; Yeung SC; Shete S
BMC Genet; 2016 Feb; 17():40. PubMed ID: 26872611
[TBL] [Abstract][Full Text] [Related]
16. Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy.
Epstein JB; Klasser GD
Expert Opin Emerg Drugs; 2006 May; 11(2):353-73. PubMed ID: 16634706
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
Beaven AW; Shea TC
Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of how to prevent mucositis induced by chemoradiotherapy].
Tosaka C; Tajima H; Inoue T; Moya M; Kobayashi M; Miura K; Tada Y; Masubuchi T; Hushimi C; Kamata S
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1647-51. PubMed ID: 21996960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
